These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8797603)

  • 1. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
    Stemmermann GN; Noffsinger A; Fenoglio-Preiser CM
    Cancer Res; 1996 Sep; 56(18):4267; author reply 4272-4. PubMed ID: 8797603
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
    Ames BN; Gold LS
    Cancer Res; 1996 Sep; 56(18):4267-9; author reply 4272-4. PubMed ID: 8797604
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
    Cohen SM; Ellwein LB
    Cancer Res; 1996 Sep; 56(18):4269-70; author reply 4272-3. PubMed ID: 8797605
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
    Butterworth BE
    Cancer Res; 1996 Sep; 56(18):4270-2; author reply 4272-4. PubMed ID: 8797606
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence Re: Farber E: Cell proliferation is not a major risk factor for cancer. Mod Pathol 9:606, 1996.
    Morris SA
    Mod Pathol; 1996 Nov; 9(11):1094-5. PubMed ID: 8933525
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence Re: Farber E: Cell proliferation is not a major risk factor for cancer. Mod Pathol 9:606, 1996.
    O'Connell JT
    Mod Pathol; 1996 Nov; 9(11):1092-3. PubMed ID: 8933524
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity.
    Farber E
    Cancer Res; 1995 Sep; 55(17):3759-62. PubMed ID: 7641190
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of cancer risk prediction: "What is my risk of getting breast cancer"?
    Elmore JG; Fletcher SW
    J Natl Cancer Inst; 2006 Dec; 98(23):1673-5. PubMed ID: 17148763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastric neoplasia. Metaplasia, atrophy, and dysplasia. Clinical course times].
    de la Torre Bravo A
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():66-7. PubMed ID: 15146802
    [No Abstract]   [Full Text] [Related]  

  • 10. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan.
    Iijima K; Koike T; Abe Y; Inomata Y; Sekine H; Imatani A; Nakaya N; Ohara S; Shimosegawa T
    Am J Gastroenterol; 2007 Aug; 102(8):1603-9. PubMed ID: 17488251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of gastric intestinal metaplasia and its subtypes.
    Eriksson NK; Kärkkäinen PA; Färkkilä MA; Arkkila PE
    Dig Liver Dis; 2008 May; 40(5):355-60. PubMed ID: 18291729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
    Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer.
    Baldini L; Pretolani S; Bonvicini F; Miglio F; Epifanio G; Gentiloni Silveri N; Stefanelli ML; Bernardi M; Gasbarrini G
    Panminerva Med; 1999 Sep; 41(3):187-92. PubMed ID: 10568114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How harmful is the presence of intestinal metaplasia in the stomach?
    Zullo A; Hassan C
    Gastroenterology; 2009 Apr; 136(4):1461-2; author reply 1462. PubMed ID: 19245871
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atypical metastasis of stomach carcinoma].
    Friedrich T; Kellermann S; Leinung S
    Zentralbl Chir; 1997; 122(2):117-21. PubMed ID: 9173755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort.
    Decarli A; Calza S; Masala G; Specchia C; Palli D; Gail MH
    J Natl Cancer Inst; 2006 Dec; 98(23):1686-93. PubMed ID: 17148770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
    Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are patients referred to the oncology clinic in early or late tumor stages in a group 2 hospital?].
    Marcos Sánchez F; Albo Castaño I; Viana Alonso A; Casallo Blanco S; Juárez Ucelay F
    An Med Interna; 2006 Mar; 23(3):143-4. PubMed ID: 16752447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.